Form 4: Banzai International CFO Mark Musburger Reports Stock Option Grant
SEC Form 4 Filing
Chief Financial Officer Mark Musburger reports the acquisition of stock options in Banzai International, Inc.
Summary
- On May 14, 2024, Mark Musburger, the CFO of Banzai International, Inc., reported the acquisition of stock options.
- These options are for Class A Common Stock.
- Musburger now directly owns 75,000 stock options with an exercise price of $5, 50,000 stock options with an exercise price of $2 and 25,000 stock options with an exercise price of $1.
- The options vest and become exercisable as to 25% of the shares on May 14, 2025, and 1/48th of the shares on the last day of each month following that date.
- The options expire on May 14, 2034.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of stock option grants, which is neither particularly positive nor negative. It's a standard part of executive compensation.
Positives
- The granting of stock options to the CFO aligns his interests with those of the shareholders.
Future Outlook
NA
Industry Context
Stock option grants are a common form of executive compensation in the technology industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages, particularly in growth-oriented companies like Banzai International.
- The vesting schedule of 25% after one year followed by monthly vesting is a fairly standard practice.
- Comparing the size of the grant to similar companies and CFO roles would require further analysis of Banzai's compensation policies and peer group data.
Stakeholder Impact
- The stock option grant could incentivize the CFO to improve company performance, benefiting shareholders.
- Employees may view the grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/14/2024 | Date of the stock option grant. |
| 05/14/2025 | 25% of the stock options vest and become exercisable. |
| 05/14/2034 | Expiration date of the stock options. |
| 05/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.